Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Paula Rojas-García"'
Autor:
Paula Rojas-García, Fabiola Sáez-Delgado, María Graciela Badilla-Quintana, Laura Jiménez-Pérez
Publikováno v:
Texto Livre: Linguagem e Tecnologia, Vol 15 (2022)
Este artículo tiene por objetivo sistematizar información empírica sobre las intervenciones de videojuegos educativos en el nivel de Educación Secundaria, mediante la descripción de los participantes, caracterización de la variable independient
Externí odkaz:
https://doaj.org/article/0ad8668154e04e48ba3f7f3dc9608045
Autor:
Diana Escuder Vieco, Jorge Arenas Vidal, Paula Rojas García, Marino J Gónzález, Nadia Raquel García Lara, Carmen Rosa Pallás Alonso
Publikováno v:
International Breastfeeding Journal, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background High-temperature short-time (HTST) pasteurization (72–75 °C, 15 s) is an alternative treatment to traditional Holder pasteurization (HoP) (62ºC, 30 min) for donor milk. HTST pasteurization guarantees the milk’s microbiologic
Externí odkaz:
https://doaj.org/article/f995ec8e4a074b168033ad2e0d4e3f80
Autor:
Maarten J. Postma, Paula Rojas García, Simon van der Pol, Fernando Antoñanzas, Roberto Rodríguez-Ibeas, Marino González, Carmelo Juárez-Castelló, Antoinette D I van Asselt
Publikováno v:
Antibiotics, Vol 10, Iss 55, p 55 (2021)
Antibiotics
Antibiotics
Background: The most recommended treatment for a Helicobacter pylori infection is high doses of combined antibiotics. The objective of this article is to perform a systematic review of the economic evaluation studies applied to assess the efficiency
Autor:
Fernando Jesús Antoñanzas Villar, Simon van der Pol, Antoinette D I van Asselt, Paula Rojas García, Maarten J. Postma
Publikováno v:
PharmacoEconomics
Pharmacoeconomics, 39(12), 1355-1363. ADIS INT LTD
Pharmacoeconomics
RIUR. Repositorio Institucional de la Universidad de La Rioja
instname
Pharmacoeconomics, 39(12), 1355-1363. ADIS INT LTD
Pharmacoeconomics
RIUR. Repositorio Institucional de la Universidad de La Rioja
instname
Cost-effectiveness analyses (CEAs) can be used to assess the value of diagnostics in clinical practice. Due to the introduction of the European in vitro diagnostic and medical devices regulations, more clinical data on new diagnostics may become avai
Autor:
Fernando Jesús Antoñanzas Villar, Paula Rojas García, Simon van der Pol, Antoinette D I van Asselt, Maarten J. Postma
Publikováno v:
PharmacoEconomics
Pharmacoeconomics
Pharmacoeconomics
Background Diagnostic testing for respiratory tract infections is a tool to manage the current COVID-19 pandemic, as well as the rising incidence of antimicrobial resistance. At the same time, new European regulations for market entry of in vitro dia
Autor:
Paula, Rojas García, Simon, van der Pol, Antoinette D I, van Asselt, Maarten, Postma, Roberto, Rodríguez-Ibeas, Carmelo A, Juárez-Castelló, Marino, González, Fernando, Antoñanzas
Publikováno v:
Antibiotics
Background: The most recommended treatment for a Helicobacter pylori infection is high doses of combined antibiotics. The objective of this article is to perform a systematic review of the economic evaluation studies applied to assess the efficiency
Publikováno v:
Revista espanola de salud publica. 92
Risk-sharing contracts (RSC) present a novel management tool, which link the payment to the pharmaceutical company to health outcomes. The objective of this work was to know the perception of health professionals about the utility of these agreements
Autor:
Paula Rojas-Garcia, Simon van der Pol, Antoinette D. I. van Asselt, Maarten J. Postma, Roberto Rodríguez-Ibeas, Carmelo A. Juárez-Castelló, Marino González, Fernando Antoñanzas
Publikováno v:
Antibiotics, Vol 11, Iss 1, p 27 (2021)
Introduction: Sepsis is a serious and expensive healthcare problem, when caused by a multidrug-resistant (MDR) bacteria mortality and costs increase. A reduction in the time until the start of treatment improves clinical results. The objective is to
Externí odkaz:
https://doaj.org/article/8c1fb4aa8889464fa7e2b8654d98e00a
Autor:
Paula Rojas García, Simon van der Pol, Antoinette D. I. van Asselt, Maarten Postma, Roberto Rodríguez-Ibeas, Carmelo A. Juárez-Castelló, Marino González, Fernando Antoñanzas
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 55 (2021)
Background: The most recommended treatment for a Helicobacter pylori infection is high doses of combined antibiotics. The objective of this article is to perform a systematic review of the economic evaluation studies applied to assess the efficiency
Externí odkaz:
https://doaj.org/article/95e5141e24974cf29cb81c2c1e78f31f